Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region

Abstract Most disease-modifying drugs (DMDs) are contraindicated in pregnancy. Management of MS is especially challenging for pregnant patients, as withdrawal of DMDs leave the patient at risk of increased disease activity. We, a group of experts in MS care from countries in the Arab Gulf, present o...

Full description

Bibliographic Details
Main Authors: Raed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, Jaber Alkhabouri, Taoufik Alsaadi, Abdullah Alsalti, Amir Boshra, Beatriz Canibano, Samar Farouk Ahmed, Ahmed Shatila
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-06-01
Series:Neurology and Therapy
Subjects:
Breastfeeding
Disease-modifying drugs
Family planning
Multiple sclerosis
Pregnancy
Online Access:https://doi.org/10.1007/s40120-020-00201-8

Internet

https://doi.org/10.1007/s40120-020-00201-8

Similar Items